FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310704857> ?p ?o ?g. }

• W4310704857 endingPage "40" @default.
• W4310704857 startingPage "40" @default.
• W4310704857 abstract "Importance The association of 13-valent pneumococcal conjugate vaccine (PCV13) use with pneumonia hospitalization in older adults, especially those with underlying medical conditions, is not well described. Objective To evaluate the association of PCV13 use with pneumonia, non–health care–associated (non-HA) pneumonia, and lobar pneumonia (LP) hospitalization among US Medicare beneficiaries 65 years or older. Design, Setting, and Participants This cohort study with time-varying exposure assignment analyzed claims data from US Medicare beneficiaries 65 years or older enrolled in Parts A/B with a residence in the 50 US states or the District of Columbia by September 1, 2014. New Medicare Parts A/B beneficiaries within 6 months after their 65th birthday were continuously included in the cohort after September 1, 2014, and followed through December 31, 2017. Participants were censored if they died, changed enrollment status, or developed a study outcome. Most of the analyses were conducted from 2018 to 2019, and additional analyses were performed from 2021 to 2022. Exposures Use of PCV13 vaccination 14 days or more before pneumonia hospitalization. Main Outcomes and Measures Discrete-time survival models were used to estimate the incidence rate ratio (IRR) and number of pneumonia hospitalizations averted through PCV13 use. The adjusted IRR for the association of PCV13 vaccination with pneumonia hospitalization was used to estimate vaccine effectiveness (VE). Results At the end of follow-up (December 2017), 24 121 625 beneficiaries (13 593 975 women [56.4%]; 418 005 [1.7%] Asian, 1 750 807 [4.8%] Black, 338 044 [1.4%] Hispanic, 111 508 [0.5%] Native American, and 20 700 948 [85.8%] White individuals) were in the cohort; 4 936 185 (20.5%) had received PCV13 only, and 10 646 220 (79.5%) had not received any pneumococcal vaccines. More than half of the beneficiaries in the cohort were younger than 75 years, White, and had either immunocompromising or chronic medical conditions. Coverage with PCV13 increased from 0.8% (September 2014) to 41.5% (December 2017). The VE for PCV13 was estimated at 6.7% (95% CI, 5.9%-7.5%) for pneumonia, 4.7% (95% CI, 3.9%-5.6%) for non-HA pneumonia, and 5.8% (95% CI, 2.6%-8.9%) for LP. From September 2014 through December 2017, an estimated 35 127 pneumonia (95% CI, 33 011-37 270), 24 643 non-HA pneumonia (95% CI, 22 761-26 552), and 1294 LP (95% CI, 797–1819) hospitalizations were averted through PCV13 use. Conclusions and Relevance The study results suggest that PCV13 use was associated with reduced pneumonia hospitalization among Medicare beneficiaries 65 years or older, many of whom had underlying medical conditions. Increased PCV13 coverage and use of recently approved higher-valent pneumococcal conjugate vaccines may avert additional pneumonia hospitalizations in adults." @default.
• W4310704857 created "2022-12-16" @default.
• W4310704857 creator A5001352678 @default.
• W4310704857 creator A5032146239 @default.
• W4310704857 creator A5044798394 @default.
• W4310704857 creator A5049812814 @default.
• W4310704857 creator A5051487551 @default.
• W4310704857 creator A5060314796 @default.
• W4310704857 creator A5062621755 @default.
• W4310704857 creator A5064280673 @default.
• W4310704857 creator A5065362776 @default.
• W4310704857 creator A5066869339 @default.
• W4310704857 creator A5069420370 @default.
• W4310704857 creator A5071722590 @default.
• W4310704857 creator A5088097169 @default.
• W4310704857 date "2023-01-01" @default.
• W4310704857 modified "2023-10-01" @default.
• W4310704857 title "Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017" @default.
• W4310704857 cites W1963985157 @default.
• W4310704857 cites W2061326496 @default.
• W4310704857 cites W2092545077 @default.
• W4310704857 cites W2097129414 @default.
• W4310704857 cites W2129168200 @default.
• W4310704857 cites W2136544583 @default.
• W4310704857 cites W2149176649 @default.
• W4310704857 cites W2182945617 @default.
• W4310704857 cites W2791372651 @default.
• W4310704857 cites W2805601670 @default.
• W4310704857 cites W2805602065 @default.
• W4310704857 cites W2891806275 @default.
• W4310704857 cites W2901650209 @default.
• W4310704857 cites W2913664322 @default.
• W4310704857 cites W2994892274 @default.
• W4310704857 cites W3044060862 @default.
• W4310704857 cites W3087450266 @default.
• W4310704857 cites W3162619647 @default.
• W4310704857 cites W4210247696 @default.
• W4310704857 cites W4220904942 @default.
• W4310704857 cites W4226262723 @default.
• W4310704857 cites W4234679590 @default.
• W4310704857 cites W4294350673 @default.
• W4310704857 doi "https://doi.org/10.1001/jamainternmed.2022.5472" @default.
• W4310704857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36469350" @default.
• W4310704857 hasPublicationYear "2023" @default.
• W4310704857 type Work @default.
• W4310704857 citedByCount "8" @default.
• W4310704857 countsByYear W43107048572023 @default.
• W4310704857 crossrefType "journal-article" @default.
• W4310704857 hasAuthorship W4310704857A5001352678 @default.
• W4310704857 hasAuthorship W4310704857A5032146239 @default.
• W4310704857 hasAuthorship W4310704857A5044798394 @default.
• W4310704857 hasAuthorship W4310704857A5049812814 @default.
• W4310704857 hasAuthorship W4310704857A5051487551 @default.
• W4310704857 hasAuthorship W4310704857A5060314796 @default.
• W4310704857 hasAuthorship W4310704857A5062621755 @default.
• W4310704857 hasAuthorship W4310704857A5064280673 @default.
• W4310704857 hasAuthorship W4310704857A5065362776 @default.
• W4310704857 hasAuthorship W4310704857A5066869339 @default.
• W4310704857 hasAuthorship W4310704857A5069420370 @default.
• W4310704857 hasAuthorship W4310704857A5071722590 @default.
• W4310704857 hasAuthorship W4310704857A5088097169 @default.
• W4310704857 hasConcept C120665830 @default.
• W4310704857 hasConcept C121332964 @default.
• W4310704857 hasConcept C126322002 @default.
• W4310704857 hasConcept C167704817 @default.
• W4310704857 hasConcept C187212893 @default.
• W4310704857 hasConcept C194828623 @default.
• W4310704857 hasConcept C201903717 @default.
• W4310704857 hasConcept C203014093 @default.
• W4310704857 hasConcept C22070199 @default.
• W4310704857 hasConcept C2777914695 @default.
• W4310704857 hasConcept C2778866548 @default.
• W4310704857 hasConcept C2779892413 @default.
• W4310704857 hasConcept C2781253189 @default.
• W4310704857 hasConcept C44249647 @default.
• W4310704857 hasConcept C523546767 @default.
• W4310704857 hasConcept C54355233 @default.
• W4310704857 hasConcept C61511704 @default.
• W4310704857 hasConcept C71924100 @default.
• W4310704857 hasConcept C72563966 @default.
• W4310704857 hasConcept C86803240 @default.
• W4310704857 hasConceptScore W4310704857C120665830 @default.
• W4310704857 hasConceptScore W4310704857C121332964 @default.
• W4310704857 hasConceptScore W4310704857C126322002 @default.
• W4310704857 hasConceptScore W4310704857C167704817 @default.
• W4310704857 hasConceptScore W4310704857C187212893 @default.
• W4310704857 hasConceptScore W4310704857C194828623 @default.
• W4310704857 hasConceptScore W4310704857C201903717 @default.
• W4310704857 hasConceptScore W4310704857C203014093 @default.
• W4310704857 hasConceptScore W4310704857C22070199 @default.
• W4310704857 hasConceptScore W4310704857C2777914695 @default.
• W4310704857 hasConceptScore W4310704857C2778866548 @default.
• W4310704857 hasConceptScore W4310704857C2779892413 @default.
• W4310704857 hasConceptScore W4310704857C2781253189 @default.
• W4310704857 hasConceptScore W4310704857C44249647 @default.
• W4310704857 hasConceptScore W4310704857C523546767 @default.
• W4310704857 hasConceptScore W4310704857C54355233 @default.
• W4310704857 hasConceptScore W4310704857C61511704 @default.

• next